1086 related articles for article (PubMed ID: 27797355)
1. Non-viral delivery of genome-editing nucleases for gene therapy.
Wang M; Glass ZA; Xu Q
Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
[TBL] [Abstract][Full Text] [Related]
2. Genome editing technologies to fight infectious diseases.
Trevisan M; Palù G; Barzon L
Expert Rev Anti Infect Ther; 2017 Nov; 15(11):1001-1013. PubMed ID: 29090592
[TBL] [Abstract][Full Text] [Related]
3. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
4. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
Guha TK; Edgell DR
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
[TBL] [Abstract][Full Text] [Related]
5. Genome Editing in Stem Cells for Disease Therapeutics.
Song M; Ramakrishna S
Mol Biotechnol; 2018 Apr; 60(4):329-338. PubMed ID: 29516417
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic editing of hepatocyte genome in vivo.
Ruiz de Galarreta M; Lujambio A
J Hepatol; 2017 Oct; 67(4):818-828. PubMed ID: 28527665
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
8. Delivery methods for site-specific nucleases: Achieving the full potential of therapeutic gene editing.
Liu J; Shui SL
J Control Release; 2016 Dec; 244(Pt A):83-97. PubMed ID: 27865852
[TBL] [Abstract][Full Text] [Related]
9. Genome editing comes of age.
Kim JS
Nat Protoc; 2016 Sep; 11(9):1573-8. PubMed ID: 27490630
[TBL] [Abstract][Full Text] [Related]
10. Delivery technologies for genome editing.
Yin H; Kauffman KJ; Anderson DG
Nat Rev Drug Discov; 2017 Jun; 16(6):387-399. PubMed ID: 28337020
[TBL] [Abstract][Full Text] [Related]
11. A beginner's guide to gene editing.
Harrison PT; Hart S
Exp Physiol; 2018 Apr; 103(4):439-448. PubMed ID: 29282799
[TBL] [Abstract][Full Text] [Related]
12. Basics of genome editing technology and its application in livestock species.
Petersen B
Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
[TBL] [Abstract][Full Text] [Related]
13. Advances in therapeutic CRISPR/Cas9 genome editing.
Savić N; Schwank G
Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
[TBL] [Abstract][Full Text] [Related]
14. Designed nucleases for targeted genome editing.
Lee J; Chung JH; Kim HM; Kim DW; Kim H
Plant Biotechnol J; 2016 Feb; 14(2):448-62. PubMed ID: 26369767
[TBL] [Abstract][Full Text] [Related]
15. Engineered Viruses as Genome Editing Devices.
Chen X; Gonçalves MA
Mol Ther; 2016 Mar; 24(3):447-57. PubMed ID: 26336974
[TBL] [Abstract][Full Text] [Related]
16. Research on genodermatoses using novel genome-editing tools.
Lehmann J; Seebode C; Emmert S
J Dtsch Dermatol Ges; 2017 Aug; 15(8):783-789. PubMed ID: 28622433
[TBL] [Abstract][Full Text] [Related]
17. Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN.
Ul Ain Q; Chung JY; Kim YH
J Control Release; 2015 May; 205():120-7. PubMed ID: 25553825
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
19. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
Eid A; Mahfouz MM
Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
[TBL] [Abstract][Full Text] [Related]
20. Non-viral strategies for delivering genome editing enzymes.
Li J; Røise JJ; He M; Das R; Murthy N
Adv Drug Deliv Rev; 2021 Jan; 168():99-117. PubMed ID: 32931860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
